Agios Pharmaceuticals, Inc. (AGIO)
30.23
+0.25
(+0.83%)
USD |
NASDAQ |
Feb 27, 16:00
30.24
+0.01
(+0.03%)
After-Hours: 20:00
Agios Pharmaceuticals Research and Development Expense (TTM) : 334.36M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Gilead Sciences, Inc. | 5.688B |
| CorMedix, Inc. | 12.46M |
| Alnylam Pharmaceuticals, Inc. | 1.320B |
| Enanta Pharmaceuticals, Inc. | 99.94M |
| Karyopharm Therapeutics, Inc. | 125.32M |